Bayer Aktiengesellschaft
- SEC CIK
- 0001144145
No open-market purchases or sales filed in the past year.
Current role at each company
- SNTI Senti Biosciences Holdings, Inc.10% Owneras of Mar 12, 2025
- MGX Metagenomi Therapeutics, Inc.10% Owneras of Feb 15, 2024
- AZTR Azitra, Inc.10% Owneras of Jul 24, 2023
- PYXS Pyxis Oncology, Inc.Other: Former 10% Owneras of Oct 15, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bayer Aktiengesellschaft as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SNTI Senti Biosciences Holdings, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2024 (view filing)7:38 PM ET | Dec 9 | 2 days | Bayer Aktiengesellschaft and 3 others10% Owner | PPurchase | +5.55M | – | – | –3.33M after | Derivative2 lots |